Funding

Enodia Therapeutics

France · Biotech · AI

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Visit enodiatx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed€20.7MArgobio Studio — Role not disclosedBpifrance — Role not disclosedElaia — Role not disclosedInvestSud — Role not disclosedMACSF — Role not disclosedMission BioCapital — Role not disclosedPfizer Ventures — Role not disclosedSambrinvest — Role not disclosedThe Institut Pasteur — Role not disclosedWallonie Entreprendre — Role not disclosed

Investors

Argobio StudioSeedBpifranceSeedElaiaSeedInvestSudSeedMACSFSeedMission BioCapitalSeedPfizer VenturesSeedSambrinvestSeedThe Institut PasteurSeedWallonie EntreprendreSeed

Coverage

Jan 8, 2026Enodia Therapeutics · Seed

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesenodiatx.com ↗